Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1997-07-23
2000-12-12
Fitzgerald, David L.
Drug, bio-affecting and body treating compositions
Lymphokine
424 852, A61K 3818, A61K 3819, A61K 3820
Patent
active
06159461&
ABSTRACT:
Compositions comprising c-kit ligand, TNF-.alpha., and a hematopoietic factor are useful to promote the expansion of peripheral blood cells or the expansion and differentiation of hematopoietic progenitor cells.
REFERENCES:
patent: 5199942 (1993-04-01), Gillis
patent: 5399493 (1995-03-01), Emerson et al.
patent: 5409825 (1995-04-01), Hoffman et al.
patent: 5767074 (1998-06-01), Besmer et al.
patent: 6001803 (1999-12-01), Besmer et al.
Anderson, D.M. Molecular Cloning of Mast Cell Growth Factor, a Hematopietin That Is Active In Both Membrane Bound And Soluble Forms. Cell (1990) 63:235-243 (Exhibit 8).
Bazan, J.F. Genetic And Structural Homology Of Stem Cell Factor and Macrophage Colony-Stimulating factor. Cell (1991) 65:9-10 (Exhibit 9).
Besmer, P. A New Acute Transforming Feline Retrovirus and Relationship of its Oncogene v-kit with the Protein Kinase Gene Family. Nature (1986) 320:415-421 (Exhibit 10).
Bischoff, S.C., and Dahinden, C.A. C-Kit Ligand: A Unique Potentiator Of Mediator Release by Human Lung Mast Cells. J. Exp. Med. (1992) 175:237-244 (Exhibit 11).
Chabot, B. The Proto-Oncogene C-Kit Encoding A Transmembrane Tyrosine Kinase Receptor Maps To The Mouse W Locus. Nature (1988) 335:88-89 (Exhibit 12).
Copeland, N.G. Mast Cell Growth Factor Maps near the steel Locus On Mouse Chromosome 10 and Is Deleted In A Number OffSteel Alleles. Cell (1990) 63:175-183 (Exhibit 13).
Flanagan, J.G. and Leder, P. The Kit-Ligand: A Cell Surface Molecule Altered In Steel Mutant Fibroblasts. Cell (1990) 63:185-194 (Exhibit 14).
Flanagen, J.G., et al. Transmembrane Form Of The Kit Ligand Growth Factor Is Determined By Alternative Splicing And Is Missing in the SId Mutant. Cell (1991) 64:1025-1035 (Exhibit 15).
Huang, E., et al. The Hematopoietic Growth Factor KL Is Encoded by SI Locus and is the Ligand of the C-Kit Receptor, the Gene Product of the W Locus. Cell (1990) 63:225-233 (Exhibit 17).
Karhumaki, E. An Improved Enrichment Method For Functionally Competent, Highly Purified Peripheral Blood Dendritic Cells And its Application To HIV-Infected Blood Samples. Clin. Exp. Immunol. (1993) (Exhibit 18).
Martin, F.H., et al. Primary Structure and Functional Expression of rat and human Stem Cell Factor DNAs. Cell (1990)63:203-211 (Exhibit 19).
Majumder, S., et al. C-Kit Protein, a Transmembrane Kinase: Identification In Tissues and Characterization. Molecular and Cellular Biology. (1988) 8:4896-4903 (Exhibit 20).
Metcalf, D. and Nicola, N.A., Direct Proliferative Actions Of STem Cell Factor On Murine Bone Marrow Cells In Vitro: effects of Combination With Colony-Stimulating Factors. Proc. Natl. Acad. Sci. USA 886239-6243 (Exhibit 21).
Moore, M.A.S., Clinical Implications of Positive and Negative Hematopoietic Stem Cell Regulators. The Journal of The American Society of Hematology (1991) 78:1-19 (Exhibit 22).
Moore, M.A.S., and Warren, D.J. Synergy of Interleukin 1 and Granulocyte Colony-Stimulating Factor: In Vivo stimulation of Stem Cell Recovery and Hematopoietic Regeneration Following 5-Fluorouracil Treatment of Mice. Proc. Natl. Acad. Sci. USA (1987) 84:7134-7138 (Exhibit 23).
Muench, M.O., et al. Interactions Among Colony-Stimulating Factors, IL-1b, IL-6, and Kit-Ligand In The Regulation Of Primitive,Murine Hematopoietic Cells. Exp. Hematol. (1992) 20:339-349 (Exhibit 24).
Nocka, K.H., et al. Candidate Ligand For C-Kit: Purification of a Fibroblast-Derived Mast Cell Growth Factor. Experimental Hematology (1990) 18:253 (Exhibit 25).
Nocka, K. et al. Expression of C-Kit Gene Products In Known Cellular Targets Of W Mutations In Normal And W Mutant Mice-Evidence For An Impaired C-Kit Kinase In Mutant Mice. Genes & Development (1989) 3:816-826 (Exhibit 26).
Nocka, K, et al. Molecular Bases Of Dominant Negative and Loss Of Function Mutations At the Murine C-Kit/White Spotting Locus: W37, WV, W41, and W. The EMBO Journal (1990) 9:1805-1813 (Exhibit 27).
Nocka, K, et al. Candidate Ligand For The C-Kit Transmembrane Kinase Receptor: KL, A Fibroblast Derived Growth Factor Stimulates Mast Cells And Erythroid Progenitors. The EMBO Journal (1990) 9:3287-3294 (Exhibit 28).
Orr-Urtreger, A. et al. Development Expression of C-Kit, A Proto-Oncogene Encoded By The W Locus. Development (1990) 109:911-923 (Exhibit 29).
Qiu,F., et al. Primary Structure C-Kit: Relationship With The CSF-1/PDGF Receptor Kinase Family-Oncogene Activation Of V-Kit Involves Deletion Of Extracellular Domain and C Terminus. IRL Press Limited, Oxford, England. (Exhibit 30).
Reith, A.D., et al. W Mutant Mice With Mild Or Severe Developmental Defects Contain Distinct Point Mutations In The Kinase Domain Of The C-Kit Receptor. Genes & Development (1990) 4:390-400 (Exhibit 31).
Tan, J.C., et al. The Dominant W42 Spotting Phenotype Results From A Missense Mutation In The C-Kit Receptor Kinase. Science Reports (1990) 209-212. (Exhibit 32).
Taxi, A., et al. Evidence That Granulocyte Macrophage-Colony Stimulating Factor Regulates The Distribution And Differentiated State Of Dendritic Cells/Langerhans Cells In Human Lung And Lung Cancers. (1993) 91:566-576 (Exhibit 33).
Thomas, R., et al. Isolation and Characterization of Human Peripheral Blood Dendritic Cells. The Journal of Immunology (1993) 150:821-834 (Exhibit 34).
Williams, D.E., et al. Identification of a Ligand for the C-Kit Proto Oncogene. Cell (1990) 63:167-174 (Exhibit 35).
Yarden, Y., et al. Human Proto-Oncogene C-Kit: A New Cell Surface Recept Tyrosine Kinase For An Unidentified Ligand. The EMBO Journal (1987) 6:3341-3351 (Exhibit 36).
Zsebo, K.M., et al. Identification, Purification, and Biological Characterization of Hematopoietic Stem Cell Factor From Buffalo Rat Liver-Conditioned Medium. Cell (199) 63:195-201 (Exhibit 37).
Zsebo, K.M., et al. Stem Cell Factor Is Encoded At The SI Locuse of the Mouse and is the Ligand for the C-Kit Tyrosine Kinase Receptor. Cell (1990) 63:213-224 (Exhibit 38).
Besmer Peter
Buck Jochen
Moore Malcolm A. S.
Nocka Karl
Fitzgerald David L.
Sloan-Kettering Institute for Cancer Research
White John P.
LandOfFree
Use of c-kit ligand with TNF-.alpha. and hematopoietic factors f does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of c-kit ligand with TNF-.alpha. and hematopoietic factors f, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of c-kit ligand with TNF-.alpha. and hematopoietic factors f will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-213472